http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2017261487-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b2e893abcc9018a3fe6594eebd496cba |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-202 |
| filingDate | 2017-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63a2d8a73d5b25abf41e42edc88a021e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_223d8c337a20cb2c8956e40b284c97a4 |
| publicationDate | 2017-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AU-2017261487-A1 |
| titleOfInvention | Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same |
| abstract | The present invention relates to, inter alia, pharmaceutical compositions comprising EPA and one or more cardiovascular agents, and to therapeutic methods for treating various diseases and disorders using the same. |
| priorityDate | 2009-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 871.